Occudo Quantitative Strategies’s Antares Pharma, Inc. ATRS Stock Holding History

Occudo Quantitative Strategies’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,168	Closed	-$58K	–	1473
2022 Q1	$58K	Sell	14,168 -17,208	-55%	-$62.4K	﹤0.01%	1072
2021 Q4	$112K	Sell	31,376 -3,536	-10%	-$12.4K	0.01%	947
2021 Q3	$127K	Buy	+34,912	New	+$141K	0.02%	906

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Occudo Quantitative Strategies's ATRS Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,168 shares — an estimated $58K sold.

Occudo Quantitative Strategies first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $127K in Q3 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Occudo Quantitative Strategies reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Occudo Quantitative Strategies sold 14,168 Antares Pharma, Inc. shares in Q2 2022, an estimated $58K.
Occudo Quantitative Strategies first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Occudo Quantitative Strategies's Antares Pharma, Inc. position peaked at $127K in Q3 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.